1. Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency
   TingTing Tseng et al, 2017, Oncotarget CrossRef
2. Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
   Cong Wang et al, 2019, Frontiers in Genetics CrossRef
3. 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology
   Richard J. Epstein et al, 2021, Journal of Oncology CrossRef
4. Pre-mRNA Splicing and Disease
   Michael R. Ladomery et al, 2016, The Functional Nucleus CrossRef
5. Fibroblast Growth Factor Family in the Progression of Prostate Cancer
   Jun Teishima et al, 2019, Journal of Clinical Medicine CrossRef
6. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
   Subhasmita Mahapatra et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
7. Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer
   Sara Pinto Teles et al, 2019, Cancers CrossRef
8. Emerging Roles of Fibroblast Growth Factor 10 in Cancer
   Natasha S. Clayton et al, 2018, Frontiers in Genetics CrossRef
9. The FGF/FGFR system in the physiopathology of the prostate gland
   Arianna Giacomini et al, 2021, Physiological Reviews CrossRef
10. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
    Jakub Szymczyk et al, 2021, Cancers CrossRef
11. Updates on Molecular and Biochemical Development and Progression of Prostate Cancer
    Omar Fahmy et al, 2021, Journal of Clinical Medicine CrossRef
12. Receptor tyrosine kinases: biological functions and anticancer targeted therapy
    Nan Zhang et al, 2023, MedComm CrossRef